Abstract:Abstract Background: Accumulating clinical evidence demonstrated that gut microbiota (GM) transfer substantially ameliorated autistic symptoms, implying a role of GM in autism spectrum disorder (ASD). Continuous investigation reported GM alteration in ASD individuals, while inconsistency also persists in the abundance of bacterial taxon, as well as their metabolites. Due to deficiencies of stringent study designs, multi-omics assessment, and even animal tests, such data heterogeneity is yet to be addressed, which impedes establishing a causal effect of a specific microbiome-metabolome axis on pathogenesis of ASD.Results: We developed a participant recruitment and sampling procedure that fully considered possible intergroup and intragroup confounders, including age, diet, severity of ASD, and stool consistency. To tease out biological features of ASD from an overarching investigation on metabolome, composition and function of GM, we compared faecal samples collected from 123 children with either mild ASD (n=56) or typical development (TD) (n=67). Metabolite profiling of targeted metabolomics screened and validated a significantly higher ratio of gamma-aminobutyric acid (GABA) to glutamate (Glu) as a metabolic signature of ASD. Linked to autistic symptomatology, the microbial GABA/Glu ratio independently distinguished ASD from TD subjects, particularly at 3-5 years. The 16S rRNA gene sequencing displayed substantially declined GM richness but over-presented genus Escherichia in ASD, which was profoundly associated with the increased GABA/Glu ratio. Metagenomics confirmed both structural and metabolic dysbiosis of GM via revealing consistent changes in microbial components and Escherichia abundance, and highlighting overall hypofunction of the GM and imbalanced GABA/Glu synthesis in ASD. We further identified a series of E. coli-specific adhesins that linked Escherichia colonization with GABA production. Quantitative PCR validation supported increment of Escherichia-specific glutamate decarboxylase, promoting GABA synthesis. Further, challenge of healthy weaning mice with gut commensal E. coli induced significant social deficiency, but not abnormalities in repetitive, locomotor, recognition memory- and anxiety-related behaviors. Conclusions: Our multi-omics study elucidated a microbe-metabolite axis out of GM dysbiosis in mild ASD, characterized by over-presented Escherichia and concomitant GABA/Glu imbalance, which were well-marked features of ASD-linked GM at an early age, and potential causal factors of autistic symptomology. Our study provided insight into importance of microbial excitatory/inhibitory neurotransmitters imbalance in diagnosis and therapeutic treatment of ASD.

Gut microbiota functional profiling in autism spectrum disorders: bacterial VOCs and related metabolic pathways acting as disease biomarkers and predictors

The many faces of microbiota-gut-brain axis in autism spectrum disorder

Stratification of Gut Microbiota Profiling Based on Autism Neuropsychological Assessments

Gut Microbiota Biomarkers in Autism Spectrum Disorders

Potential of gut microbiome for detection of autism spectrum disorder

Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach

Multi-level analysis of the gut–brain axis shows autism spectrum disorder-associated molecular and microbial profiles

The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders

Correction of Batch Effect in Gut Microbiota Profiling of ASD Cohorts from Different Geographical Origins

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder

Revealing the gut microbiome mystery: A meta-analysis revealing differences between individuals with autism spectrum disorder and neurotypical children

Intestinal Barrier Dysfunction and Microbiota–Gut–Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder

Multi-omic Analysis along the Gut-Brain Axis Points to a Functional Architecture of Autism

Autism Spectrum and gastrointestinal health: Screening on the influence of environmental factors on gastrointestinal problems

Multikingdom and functional gut microbiota markers for autism spectrum disorder

Relationships between Gut Microbiota and Autism Spectrum Disorders: Development and Treatment

Gut microbiota of children with autism spectrum disorder and healthy siblings: A comparative study

Microbiome-Specific Statistical Modeling Identifies Interplay Between Gastrointestinal Microbiome and Neurobehavioral Outcomes in Patients With Autism: A Case Control Study

Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder

Excess Escherichia Elicits Mild Autism Spectrum Disorder in Young Subjects Via Disturbing the Balance of Gut Microbial GABA Metabolism